Cadence Neuroscience raises $26M for epilepsy neuromod therapy
Neurmodulation technology developer Cadence Neuroscience announced that it secured $26 million in a Series B financing round.
Source: massdevice.com
Gerry Brunk News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Gerry Brunk. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Gerry Brunk Today - Breaking & Trending Today
Cadence Neuroscience Raises $26M in Series B Financing
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
Cadence Neuroscience Secures $26 Million in Series B Financing for Clinical Trials of Epilepsy Neuromodulation Therapy
/PRNewswire/ -- Cadence Neuroscience announced today that it has secured $26 million in Series B financing. The round was led by Angelini Lumira Biosciences...
Source: prnewswire.com
LAVA Medtech Acquisition Corp. Announces the Separate Trading of its shares of Class A Common Stock and Warrants, Commencing December 17, 2021
16.12.2021 - Waltham, MA, Dec. 16, 2021 (GLOBE NEWSWIRE) - LAVA Medtech Acquisition Corp. (the “Company”) (NASDAQ: LVACU) announced today that, commencing December 17, 2021, holders of the units sold in the Company’s initial public offering may elect to ...
Source: wallstreet-online.de
LAVA Medtech Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering
27.10.2021 - Waltham, MA , Oct. 26, 2021 (GLOBE NEWSWIRE) - LAVA Medtech Acquisition Corp. (the “Company”) today announced the pricing of its initial public offering of 10,000,000 units at a price of $10.00 per unit. The units will be listed on the Nasdaq ...
Source: wallstreet-online.de